Journal
EARLY HUMAN DEVELOPMENT
Volume 105, Issue -, Pages 35-39Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.earlhumdev.2016.12.003
Keywords
Bronchopulmonary Dysplasia; Pulmonary hypertension; Microbiome; Biomarkers; Systems biology
Categories
Ask authors/readers for more resources
The pathogenesis of Bronchopulmonary Dysplasia (BPD) is multifactorial and the clinical phenotype of BPD is extremely variable. Predicting BPD is difficult, as it is a disease with a clinical operational definition but many clinical phenotypes and endotypes. Most biomarkers studied over the years have low predictive accuracy, and none are currently used in routine clinical care or shown to be useful for predicting longer-term respiratory outcome. Targeted cellular and humoral biomarkers and novel systems biology 'omic' based approaches including genomic and microbiomic analyses are described in this review. (C) 2016 Published by Elsevier Ireland Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available